EU support for New Nordic Life Science Venture Fund - Eir Ventures

Friday, 10 July, 2020
Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new Fund of EUR 76m. Eir Ventures will invest in innovative companies with products & technologies addressing significant unmet medical needs and with the potential to improve the life of patients. The fund is launched with, among other investors, a EUR 20m investment from the European Investment Fund, made possible with support from the European Fund for Strategic Investments and InnovFin Equity under H2020.
Article
#H2020

#H2020